1. Home
  2. CREX vs BRNS Comparison

CREX vs BRNS Comparison

Compare CREX & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • BRNS
  • Stock Information
  • Founded
  • CREX N/A
  • BRNS 2016
  • Country
  • CREX United States
  • BRNS United Kingdom
  • Employees
  • CREX N/A
  • BRNS N/A
  • Industry
  • CREX EDP Services
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREX Technology
  • BRNS Health Care
  • Exchange
  • CREX Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • CREX 45.4M
  • BRNS 52.0M
  • IPO Year
  • CREX N/A
  • BRNS 2021
  • Fundamental
  • Price
  • CREX $4.36
  • BRNS $1.28
  • Analyst Decision
  • CREX Strong Buy
  • BRNS Strong Buy
  • Analyst Count
  • CREX 1
  • BRNS 2
  • Target Price
  • CREX $10.00
  • BRNS $4.00
  • AVG Volume (30 Days)
  • CREX 45.9K
  • BRNS 20.5K
  • Earning Date
  • CREX 08-14-2024
  • BRNS 08-08-2024
  • Dividend Yield
  • CREX N/A
  • BRNS N/A
  • EPS Growth
  • CREX N/A
  • BRNS N/A
  • EPS
  • CREX N/A
  • BRNS N/A
  • Revenue
  • CREX $51,426,000.00
  • BRNS N/A
  • Revenue This Year
  • CREX $25.43
  • BRNS $27.18
  • Revenue Next Year
  • CREX $20.71
  • BRNS N/A
  • P/E Ratio
  • CREX N/A
  • BRNS N/A
  • Revenue Growth
  • CREX 26.01
  • BRNS N/A
  • 52 Week Low
  • CREX $1.22
  • BRNS $1.11
  • 52 Week High
  • CREX $5.20
  • BRNS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • CREX 47.29
  • BRNS 44.55
  • Support Level
  • CREX $4.41
  • BRNS $1.11
  • Resistance Level
  • CREX $4.60
  • BRNS $1.43
  • Average True Range (ATR)
  • CREX 0.21
  • BRNS 0.09
  • MACD
  • CREX 0.02
  • BRNS 0.01
  • Stochastic Oscillator
  • CREX 51.92
  • BRNS 53.12

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: